|
SOCS3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.889000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.879200E-01 |
| Normal-vs-Stage2 |
8.161400E-01 |
| Normal-vs-Stage3 |
7.907000E-01 |
| Normal-vs-Stage4 |
5.846800E-01 |
| Stage1-vs-Stage2 |
8.832600E-01 |
| Stage1-vs-Stage3 |
8.748800E-01 |
| Stage1-vs-Stage4 |
5.791600E-01 |
| Stage2-vs-Stage3 |
9.663000E-01 |
| Stage2-vs-Stage4 |
8.433800E-01 |
| Stage3-vs-Stage4 |
7.152800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.224800E-01 |
| Normal-vs-AfricanAmerican |
8.497200E-01 |
| Normal-vs-Asian |
4.045000E-01 |
| Caucasian-vs-AfricanAmerican |
9.533000E-01 |
| Caucasian-vs-Asian |
2.392400E-01 |
| AfricanAmerican-vs-Asian |
3.647600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.489600E-01 |
| Normal-vs-Female |
2.625000E-01 |
| Male-vs-Female |
4.322100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.795400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.822000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.029800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.688400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.430800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.592810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.587400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.476200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.097400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.593040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.004800E-01 |
| Normal-vs-Grade 2 |
7.768200E-01 |
| Normal-vs-Grade 3 |
6.785600E-01 |
| Normal-vs-Grade 4 |
1.538380E-01 |
| Grade 1-vs-Grade 2 |
5.297400E-01 |
| Grade 1-vs-Grade 3 |
4.547000E-01 |
| Grade 1-vs-Grade 4 |
6.957000E-01 |
| Grade 2-vs-Grade 3 |
2.758200E-01 |
| Grade 2-vs-Grade 4 |
1.715830E-01 |
| Grade 3-vs-Grade 4 |
1.722140E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.064400E-01 |
| Normal-vs-ccB subtype |
3.010000E-01 |
| ccA subtype-vs-ccB subtype |
6.935300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.498600E-01 |
| Normal-vs-N1 |
8.603200E-01 |
| N0-vs-N1 |
7.857600E-01 |
|
|
